Accustem Sciences Inc.

ACUT · OTC · SIC 2834: Pharmaceutical Preparations
32
SEC Filings
$0.2575
Close 2026-05-27

Business Summary

Company Overview We are a clinical stage diagnostics company dedicated to improving quality of life and outcomes for the more than 18 million people worldwide who are diagnosed with cancer each year. Our plan is to develop and commercialize a suite of novel genomic tests that support decision making along the entire continuum of oncology care. Our focus will be the launch of our proprietary genomic tests, MSC (MicroRNA Signature Classifier) for patients with lung nodules and StemPrintER for pati...

Latest Stock Quote

ACUT 2026-05-27 $0.2575 O:$0.2575 H:$0.2575 L:$0.2575 Vol:0.0M VWAP:$0.262
origin leaf: 45c0565eae16ed7e3f15e4fdab4168035a884ac59419af76004e28e3490ac13c

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-04-032024-12-310001641172-25-002594EDGAR56K words
2024-03-222023-12-310001493152-24-010938EDGAR—
2023-02-152022-12-310001493152-23-005208EDGAR—
2022-04-182021-12-310001493152-22-010172EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001493152-25-021919EDGAR14K words
2025-08-142025-06-300001641172-25-023786EDGAR—
2025-05-202025-03-310001641172-25-011721EDGAR—
2024-11-182024-09-300001493152-24-046438EDGAR—
2024-09-162024-06-300001493152-24-036330EDGAR—
2024-05-202024-03-310001493152-24-020584EDGAR—
2023-11-132023-09-300001493152-23-040286EDGAR—
2023-08-142023-06-300001493152-23-028164EDGAR—
2023-05-052023-03-310001493152-23-015555EDGAR—
2022-11-082022-09-300001493152-22-030905EDGAR—
2022-08-122022-06-300001493152-22-022218EDGAR—
2022-05-202022-03-310001493152-22-014587EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-11-260001493152-25-025156EDGAR1K words
2024-12-300001493152-24-052550EDGAR—
2024-04-100001493152-24-014171EDGAR—
2023-06-090001493152-23-020727EDGAR—
2023-06-070001493152-23-020328EDGAR—
2022-11-160001493152-22-032628EDGAR—
2022-10-140001493152-22-028454EDGAR—
2022-06-210001493152-22-017353EDGAR—
2022-04-050001493152-22-009142EDGAR—
2022-03-100001493152-22-006524EDGAR—

32 total filings indexed. 6 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001850767
TickerACUT
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ddb8f970d6d01b7c3fe65b473edc89dc86c8dad3aaaf74ddae5a55658f6269ff
parent: 051e951a84dc6b3a622151feb171921f004fc7e57fbbd4bb82f6334fa1370768
content hash: ee4126f1889af325994bb1849ba979428dc430b62475f5dd225c91963ec58ba9
signed: 2026-06-02T19:00:04.302Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf